TrialDigestive diseases and sciences2022

Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.

Natsuki Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.